๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers Clinical trials China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Phase III Clinical Trial of Lot-to-lot Consistency of Recombinant Herpes Zoster Vaccine (CHO Cell).
NCT06654700Herpes Zoster
MAXVAX Biotechnology Limited Liability Company
Phase 3
1,200
Zhengzhou
2024-12-09
Recruiting
A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors
NCT06625593Advanced Solid Tumor
BeOne Medicines
Phase 1
168
Bengbu, Hefei, Beijing, Fuzhou, Xiamen, Nanning, Shijiazhuang, Harbin
2024-12-09
Recruiting
Intrathecal Injection Pemetrexed And Bevacizumab in Patients With Leptomeningeal Metastases in NSCLC
NCT06663306Lung Cancer (NSCLC), Leptomeningeal Metastasis
Shanghai Chest Hospital
Phase 1
19
Shanghai
2024-12-09
Recruiting
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
NCT06679140COVID-19 SARS-CoV-2 Infection
Pfizer
Phase 3
2,330
Chizhou, Beijing, Xiamen, Guangzhou, Nanning, Changsha, Nanchang, Changchun
2024-12-08
Recruiting
Blinatumomab in Refractory Active Childhood Systemic Lupus Erythematosus
NCT06789107Systemic Lupus Erythematosus (SLE), Children, Blinatumomab
Mao Jianhua
Phase 1
6
Hangzhou
2024-12-08
Recruiting
Comparision of Endoscopic Discectomy and Microdiscectomy for the Treatment of Lumbar Spinal Stenosis
NCT06719037Lumbar Spinal Stenosis
Qilu Hospital of Shandong University
Not applicable
324
Jinan
2024-12-08
Recruiting
Long-term Follow-up Study of BRL-101 for TDT
NCT06298630Thalassemia, Beta
Bioray Laboratories
Observational
45
Guangzhou, Shenzhen, Nanning, Changsha, Tianjin, Guangxi
2024-12-08
Recruiting
A Study to Evaluate HB0034 in Healthy Chinese Adult Participants
NCT06716151Healthy
Shanghai Huaota Biopharmaceutical Co., Ltd.
Phase 1
60
Jinan
2024-12-06
Recruiting
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
NCT06667908Carcinoma, Non-Small-Cell Lung
Johnson & Johnson Enterprise Innovation Inc.
Phase 2
130
Dongguan, Guangzhou, Jinan
2024-12-06
Recruiting
A Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSS/pMMR Colorectal Cancer Patients
NCT06497985Colorectal Cancer
Chipscreen Biosciences, Ltd.
Phase 3
430
Guangzhou
2024-12-06
Recruiting
Study of SIM0508 Alone and in Combination in Patients With Advanced Solid Tumors
NCT06686745Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
130
Shanghai, Chongqing
2024-12-06
Recruiting
The Efficacy and Safety of Precision REpetitive Transcranial Magnetic Stimulation in Alleviating Motor Symptom in Parkinson's Disease
NCT06383247Parkinson Disease, Transcranial Magenetic Stimualtion, Supplementary Motor Area
Anhui Medical University
Not applicable
290
Hefei
2024-12-06
Recruiting
A Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Triple-negative Breast Cancer
NCT06878625Evaluating the Efficacy of Trop-2 ADC Combination Therapy in Advanced Triple-Negative Breast Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2
138
Tianjin
2024-12-06
Active, closed
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia
NCT06834932Dyslipidaemia
AstraZeneca
Phase 2/3
432
Baotou, Beijing, Bengbu, Changchun, Changde, Changsha, Changzhou, Chengdu
2024-12-06
Recruiting
Efficacy and Safety of Telitacicept in IgAN
NCT06654596IgA Nephropathy (IgAN), Kidney Diseases, Telitacicept, Glucocorticoid
Ruijin Hospital
Not applicable
118
Shanghai
2024-12-06
Recruiting
IB-T101 Injection for Treatment of Patients With Advanced Clear Cell Renal Cell Carcinoma
NCT06819293Advanced Clear Renal Cell Carcinoma, Adult
Grit Biotechnology
Phase 1
12
Wuhan
2024-12-06
Recruiting
Breathomics in the Diagnosis and Prediction of Radiotherapy-Induced Oropharyngeal Mucositis in Head and Neck Tumors
NCT06767488Head and Neck Tumors, Breathomics, Volatile Organic Compounds, Radiotherapy-induced Oral Mucositis
Nanfang Hospital, Southern Medical University
Observational
375
Guangzhou
2024-12-06
Recruiting
Pleural Strain by Speckle-Tracking Ultrasound: Feasibility and Driving Pressure Associations
NCT06911450Ventilation, Mechanical, ARDS (Acute Respiratory Distress Syndrome)
First Affiliated Hospital of Wannan Medical College
Observational
75
Wuhu
2024-12-05
Active, closed
Effects of DL-endopeptidase Producing Probiotics on Human Intestinal NOD2 Ligands and Related Functions
NCT06716047Microecological Therapy, Probiotic Intervention
Zhujiang Hospital
Phase EARLY_PHASE1
30
Guangzhou
2024-12-05
Recruiting
Anlotinib-based Combination Therapy in Patients with Hormone Receptor-positive๏ผˆHR+๏ผ‰ Metastatic Breast Cancer(MBC) .
NCT06734533HR+ Breast Cancer
Hunan Cancer Hospital
Observational
80
Changsha
2024-12-05
Recruiting
CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed โ‰ฅ3 Lines of Therapy.
NCT06733610Autoimmune Hemolytic Anemia, CD19/BCMA CAR T-cells, Universal Allogeneic CAR T-cells
Institute of Hematology & Blood Diseases Hospital, China
Phase 1
15
Tianjin
2024-12-05
Recruiting
nVNS for the Prevention and Treatment of Primary Headache
NCT06277063Primary Headache, Migraine in Adolescence, Migraine in Children, Cluster Headache
Nanfang Hospital, Southern Medical University
Not applicable
15
Guangzhou
2024-12-05
Recruiting
Study of SC-102 in Patients With Advanced Solid Tumors
NCT06710158Advanced Solid Cancers
Tianjin ConjuStar Biologics Co., Ltd.
Phase 1
120
Shanghai
2024-12-05
Recruiting
A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux Esophagitis
NCT06850480Reflux Esophagitis (RE)
Livzon Pharmaceutical Group Inc.
Phase 3
356
Beijing
2024-12-05
Recruiting
The Association Between Age-related Peripheral Blood Components and Treatment Efficacy in Breast Cancer
NCT06718010Breast Cancer, Age
Fudan University
Observational
120
Shanghai
2024-12-05
Recruiting
Target-specific immunoPET Imaging of Digestive System Carcinoma
NCT06715839Malignancy, Digestive Cancer, Digestive System Neoplasm, Digestive System Carcinoma
RenJi Hospital
Not applicable
400
Shanghai
2024-12-04
Recruiting
NabPE With or Without Serplulimab for Early-stage HR+/HER2- Breast Cancer.
NCT06781281Breast Cancer Invasive
Henan Cancer Hospital
Observational
709
Zhengzhou
2024-12-04
Recruiting
Application of a New Surgical Technique in Proximal Gastrectomy: a Prospective, Multicenter Randomized Controlled Study
NCT06679244Gastric Cancer Patients Undergoing Minimally Invasive Gastrectomy
Huashan Hospital
Not applicable
52
Shanghai
2024-12-04
Recruiting
Efficacy of Upadacitinib After NECS in Vitiligo
NCT06454461Vitiligo
Jilin University
Not applicable
60
Changchun
2024-12-04
Active, closed
Nipocalimab in Moderate to Severe Sjogren's Disease
NCT06741969Sjogrens Syndrome
Janssen Research & Development, LLC
Phase 3
655
Beijing, Changsha, Changzhou, Chengdu, Dazhou, Ganzhou, Guangzhou, Guiyang
2024-12-04
Recruiting
Hydrocortisone in Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors
NCT06679816Pituitary Adenoma, Pituitary Neuroendocrine Tumor
Beijing Tiantan Hospital
Phase 4
882
Beijing
2024-12-04
Recruiting
A Study of AK112, a PD-1/ VEGF Bispecific Antibody, for Resectable Hepatocellular Carcinoma With High Recurrence Risk
NCT06930573HCC
The First Affiliated Hospital of Zhengzhou University
Phase 4
30
Zhengzhou
2024-12-04
Recruiting
Study on Human Bioequivalence of Triprerelin Acetate for Injection
NCT06683066Prostate Cancer (CRPC)
The Affiliated Hospital of Qingdao University
Phase 1
120
Qingdao
2024-12-04
Recruiting
Bupivacaine Liposome Plus Bupivacaine or Ropivacaine for Pericapsular Nerve Group Block in Hip Arthroplasty (PENG)
NCT06565910Femoral Neck Fractures, Femur Head Necrosis, Hip Fractures
Huazhong University of Science and Technology
Phase 4
60
Wuhan
2024-12-04
By invitation
Comparison of the Effects of Hydromorphone and Nalbuphine Patient Controlled Analgesia in Postoperative Pain After Cesarean Section
NCT06716359Postoperative Pain, Patiet Controlled Analgesia
Huazhong University of Science and Technology
Observational
240
Wuhan
2024-12-04
Active, closed
Evaluate TQ-A3334 Combined Nucleoside (Acid) Analogs in the First Treatment/Treatment of Chronic HBV Infection
NCT06706310Chronic Hepatitis B
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2
116
Chongqing, Guangzhou, Shenzhen, Liuzhou, Wuhan, Changsha, Wuxi, Changchun
2024-12-04
Not yet open
Neoadjuvant Therapy of Targeted Immunotherapy Combined With Chemotherapy for Locally Advanced HNSCC
NCT06699498Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy, PD-L1, Anlotinib
The First Affiliated Hospital with Nanjing Medical University
Phase 2
45
Nanjing
2024-12-03
Recruiting
The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor Therapy
NCT06746194Hepatocellular Carcinoma (HCC)
Ruijin Hospital
Observational
40
Shanghai
2024-12-03
Recruiting
Trop2-targeting NIR-II Molecular Probe for Precision Diagnosis of Oral Cancer
NCT07794813Oral Squamous Cell Carcinoma (OSCC), Diagnosis
Yunnan Cancer Hospital
Observational
40
Kunming
2024-12-03
Recruiting
Postoperative Analgesia Between Paravertebral Block and Epidural Block in Esophageal Surgery
NCT06704698Pain Syndrome, Dizziness, Vomiting, Itching
Zhejiang Cancer Hospital
Not applicable
132
Hangzhou
2024-12-03
Recruiting
Oxycodone Versus Sufentanil in Patient-controlled Intravenous Analgesia After Laparoscopic Hysterectomy
NCT06690307Laparoscopic Hysterectomy
Affiliated Hospital of Nantong University
Phase 4
64
Nantong
2024-12-03
Recruiting
Neoadjuvant Chemotherapy Plus Pyrotinib and Trastuzumab for HER2-positive Breast Cancer (NEOTORCH-BREAST05)
NCT06832904HER2-positive Breast Cancer, Neoadjuvant Therapy, Pyrotinib
First Affiliated Hospital of Zhejiang University
Phase 2
33
Hangzhou
2024-12-03
Recruiting
HRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer
NCT06587061Pancreatic Cancer
Ruijin Hospital
Phase 2
30
Shanghai
2024-12-03
Recruiting
Fecal Microbiota Transplantation in Patients With Multiple Drug Resistant Klebsiella Pneumoniae Pneumonia
NCT06641778Klebsiella Pneumoniae Pneumonia
luxia Kong
Not applicable
100
Wuhan
2024-12-03
Active, closed
Sintilimab in Combination with Chemotherapy ยฑ Local Treatment for Om-G/GEJ
NCT06739161Gastroesophageal Junction Adenocarcinoma
Jiangsu Cancer Institute & Hospital
Phase 2
120
Nanjing
2024-12-02
Recruiting
The Influence of Systematic Psychological Intervention on Patients About VSD Drainage Surgery
NCT06424561Chronic Wounds
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Not applicable
40
Yiwu
2024-12-02
Recruiting
A Study of BGM0504 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and Exercise
NCT06716203Type 2 Diabetes Mellitus (T2DM)
BrightGene Bio-Medical Technology Co., Ltd.
Phase 3
207
Beijing
2024-12-02
Not yet open
Research on the Application of Patient Navigation-based Management Model of Patients After LEEP
NCT06695871Cervical Intraepithelial Neoplasias
Peking University People's Hospital
Not applicable
128
Beijing
2024-12-01
Recruiting
A Single-arm, Prospective Study of TBI + BUMEL As a Conditioning Regimen for Salvage HSCT in Patients with R/R AML
NCT06879847Relapsed or Refractory Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University
Not applicable
40
Suzhou
2024-12-01
Active, closed
Real-world Study on Fenestrated Stent for Thoracic Aortic Dissection
NCT07268755Thoracic Aortic Dissection, Thoracic Aortic Disease
Qingyou Meng
Observational
320
Shanghai
2024-12-01
Recruiting
The Addictive Diagnostic Value of Apparent Diffusion Coefficients to bpMRI in the Diagnosis of Prostate Cancer
NCT06737588Prostate Cancer
Anhui Provincial Hospital
Observational
600
Hefei, Wuhu
2024-12-01
Not yet open
Foldable Capsular Scleral Buckling Versus Vitrectomy in Medium-complex Rhegmatogenous Retinal Detachment Treatment
NCT06610786Rhegmatogenous Retinal Detachment
Eye & ENT Hospital of Fudan University
Not applicable
100
Shanghai
2024-12-01
Recruiting
Clinical Study on the Safety, Efficacy and Pharmacokinetics of Telpegfilgrastim in Pediatric Cancer Patients with Chemotherapy
NCT06857292Chemotherapy-Induced Neutropenia
Sun Yat-sen University
Phase 2
97
Guangzhou
2024-12-01
By invitation
Clinical Study of Rhythmic Auditory Stimulation for Gait Disorders
NCT06837038Hemiplegia Due to Stroke, Parkinson Disease, Parkinsonian Syndrome
YiCheng Zhu
Not applicable
60
Beijing
2024-12-01
Recruiting
Intra-arterial Chemotherapy Combined with Radiotherapy and Immunotherapy for HNSCC
NCT06725498Head and Neck Squamous Cell Carcinoma
Beijing Tongren Hospital
Phase 2
50
Beijing
2024-12-01
Recruiting
Maintenance Lurbinectedin in Combination With Serplulimab for Patients With ES-SCLC
NCT06497530Extensive-Stage Small Cell Lung Cancer
Guangzhou Institute of Respiratory Disease
Phase 2
30
Guangzhou
2024-12-01
Not yet open
Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal Cancer
NCT06670300Participants Who Had Received Second-line or Higher Advanced Melanoma and Advanced Renal Cancer
YongZhang
Phase 2
20
Zhengzhou
2024-12-01
Recruiting
Shanghai Prospective Registry Study of Ischemic Stroke
NCT07171242Ischemic Stroke
Qiang Dong
Observational
15,000
Shanghai
2024-12-01
Recruiting
Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 Encephalitis
NCT06510283Anti-N-Methyl-D-Aspartate Receptor Encephalitis
Beijing Tongren Hospital
Phase 2
10
Beijing
2024-12-01
Recruiting
Combined Recanalization Therapy for Acute Large Vessel Occlusion Stroke
NCT07115511Stroke
Tianjin Huanhu Hospital
Not applicable
64
Tianjin
2024-12-01
Not yet open
Tofacitinib in Patients With Amyotrophic Lateral Sclerosis
NCT06689982Amyotrophic Lateral Sclerosis
Beijing Tiantan Hospital
Phase EARLY_PHASE1
12
Beijing
2024-12-01
Recruiting
Development and Validation of a Risk Prediction Model for De Novo Stress Urinary Incontinence After Pelvic Floor Reconstruction Surgery
NCT07601282Pelvic Organ Prolapse (POP), Stress Urinary Incontinence (SUI)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Observational
382
Shanghai
2024-12-01
Recruiting
Effect of Premedication With Pronase on Mucosal Cleanliness During EGD
NCT06713421Esophageal Cancer, Gastric Cancer
Changhai Hospital
Not applicable
3,000
Shanghai
2024-12-01
Recruiting
The Application of Eye-Tracking Technology in Perioperative Management and Education
NCT06766539Eye-tracking Technology, Medical Education, Perioperative Management, Attention Distribution
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
300
Hangzhou
2024-12-01
Recruiting
Safety and Efficacy of IMPT or IMRT for Breast Cancer
NCT06826885Breast Cancer, Proton Therapy, Intensity Modulated Radiation Therapy, Efficacy and Safety
Ruijin Hospital
Observational
500
Shanghai
2024-12-01
Not yet open
Protective Effect of RIPC Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular Surgery (Panda VII)
NCT06707350Cardiopulmonary Bypass, Cardiovascular Diseases, Inflammatory Response During Cardiac Surgery
Nanjing Medical University
Not applicable
500
Nanjing
2024-12-01
Recruiting
Minimal Vitrectomy Surgery for Epiretinal Membrane
NCT07019896Epiretinal Membrane, Macular Edema (ME), Nuclear Cataract
Peking Union Medical College Hospital
Not applicable
140
Beijing
2024-12-01
Not yet open
Study of EPI-003 in Select Nucleos(t)Ide Analogue-Treated, Chronic Hepatitis B Patients
NCT06661148Chronic Hepatitis B, HBV (Hepatitis B Virus)
Epigenic Therapeutics, Inc
Phase 1
36
Hong Kong
2024-12-01
Recruiting
Clinical Study of Cord Blood-derived IL-10/IL-15 CD19-CAR NK in the Treatment of Refractory/Relapsed B-cell NHL
NCT06707259B-cell Non Hodgkin Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
24
Hangzhou
2024-12-01
Active, closed
Cognitive Function and EEG Brain Network Remodeling Among Users of Hearing Aids With ARHL
NCT06893432Age-related Hearing Loss, Age-related Cognitive Decline, Depression, Sleep Disturbance
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
60
Guangzhou
2024-12-01
Recruiting
Repeated Transcranial Magnetic Stimulation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Clinical Trial
NCT07581756Irritable Bowel Syndrome, Irritable Bowel Syndrome With Diarrhea (IBS-D), Repetitive Transcranial Magnetic Stimulation (rTMS), Chronic Diarrhea
The First Affiliated Hospital of Soochow University
Not applicable
46
Suzhou
2024-12-01
Recruiting
Impact of Recombinant Humanized Type III Collagen on the Immediate and Long-term Effects of Breast Tumor Surgery
NCT06725082Breast Cancer, Collagen Protein
Peking University People's Hospital
Phase 1
30
Beijing
2024-12-01
Recruiting
Efficacy of Repeated Transcranial Magnetic Stimulation Combined With a Live Probiotic Tablet (Combined Bifidobacterium, Lactobacillus, Enterococcus and Bacillus Cereus Tablets, Live) in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
NCT06960369Irritable Bowel Syndrome, Irritable Bowel Syndrome With Diarrhea (IBS-D), Repetitive Transcranial Magnetic Stimulation (rTMS), Probiotic
The First Affiliated Hospital of Soochow University
Phase 1
400
Suzhou
2024-12-01
Active, closed
Treatment Duration of IPA
NCT06583512Invasive Aspergillosis, Antifungal Therapy
Peking University People's Hospital
Observational
15
Beijing
2024-12-01
Recruiting
Evaluation of Targeted Biopsy Plus Sextant Biopsy in Diagnosis of Prostate Cancer
NCT06684652Prostate Cancer
Peking University First Hospital
Not applicable
300
Beijing
2024-12-01
Recruiting
Effects of Sleep Restriction and Stimulus Control in Chronic Insomnia Patients
NCT06658184Chronic Insomnia
Xuanwu Hospital, Beijing
Not applicable
88
Beijing
2024-12-01
Recruiting
Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer
NCT04516681Colorectal Cancer, Vitamin C, GLUT3
Fudan University
Phase 3
400
Shanhai
2024-12-01
Recruiting
A Clinical Observation Study of a Chinese Patent Medicine Combined With Tamsulosin in Improving Sleep and Nocturia Symptoms After Enucleation of the Prostate
NCT07357324Benign Prostatic Hyperplasia, Nocturia Associated With Nocturnal Polyuria
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Phase 4
136
Yiwu
2024-12-01
Recruiting
Y-90 SIRT for Unresectable HCC Larger Than 7cm
NCT06707233Hepatocellular Carcinoma Non-Resectable
Second Affiliated Hospital of Guangzhou Medical University
Phase 2
33
Guangzhou
2024-12-01
Recruiting
Artificial Intelligence-based Model for the Prediction of Occult Lymph Node Metastasis and Improvement of Clinical Decision-making in Non-small Cell Lung Cancer
NCT06684418NSCLC (Non-small Cell Lung Cancer), Artificial Intelligence (AI), Lymphnode Metastasis
Fudan University
Observational
6,000
Shanghai
2024-12-01
Recruiting
Laser Acupuncture for Idiopathic Bell's Palsy
NCT06732622Bell Palsy
Beijing Tongren Hospital
Not applicable
360
Beijing
2024-12-01
Recruiting
The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors
NCT06775080Gastrointestinal Tumors
Huashan Hospital
Phase 2
40
Shanghai
2024-12-01
Recruiting
A Prospective Study of ยนโธF-DFA PET Imaging for the Assessment of Liver Injury
NCT07050550Liver Injury
First Affiliated Hospital of Zhejiang University
Observational
45
Hangzhou
2024-12-01
Not yet open
Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer
NCT06713057Locally Advanced Thyroid Gland Carcinoma, Thyroid Cancer
West China Hospital
Phase 2
20
Chengdu
2024-12-01
Active, closed
Postural Decoding for Post-Stroke Shoulder Pain: A RCT.
NCT06763796Stroke; Sequelae
Shenzhen Baoan District Fuyong People's Hospital
Not applicable
48
Shenzhen
2024-12-01
Not yet open
Effects of rTMS on the Anxiety State of Older Patients With GAD
NCT05883774Generalized Anxiety Disorder
Yi Yang
Not applicable
100
Changchun
2024-12-01
Not yet open
Effects of Monitoring Blood Pressure During Pregnancy
NCT06217913Birth Weight, Weight Gain Trajectory
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
400
Shanghai
2024-12-01
Active, closed
The Impact of Targeted Temperature Management Duration on Thrombin Function in Cardiac Arrest Patients
NCT06543849Targeted Temperature Management, Cardiac Arrest, Thrombin Function, Treatment Duration
Tang Ziren
Not applicable
64
Beijing
2024-12-01
Not yet open
A Prospective, Non-interventional Cohort Study of Subsolid Pulmonary Nodules
NCT06458673Solitary Lung Nodule, Multiple Pulmonary Nodules
Guangdong Provincial People's Hospital
Observational
1,184
Guangzhou
2024-12-01
Active, closed
Using ctDNA to Guide Treatment Decisions for Stage III Gastric Cancer
NCT06939439Gastric Cancer Stage III
The First Affiliated Hospital with Nanjing Medical University
Phase 3
416
Nanjing
2024-12-01
Active, closed
Efficacy of Liposomal Bupivacaine Scalp Nerve Block for Postoperative Pain Management After Supratentorial Craniotomy
NCT07344181Postoperative Care
Beijing Tiantan Hospital
Not applicable
118
Beijing
2024-12-01
Recruiting
A Bladder-Sparing Treatment Strategies of Large-Volume Non-Muscle-Invasive Bladder Cancer
NCT06735287Bladder Cancer, NMIBC
The First Affiliated Hospital with Nanjing Medical University
Not applicable
60
Nanjing
2024-12-01
Recruiting
COLORECTUM+ Digital System for Postoperative Quality Improvement in Colorectal Cancer
NCT06685497Colorectal Carcinoma
RenJi Hospital
Not applicable
236
Shanghai
2024-12-01
Recruiting
Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT
NCT06693791Platelet Recovery After Umbilical Cord Blood Transplantation
Anhui Provincial Hospital
Phase 2
34
Hefei
2024-12-01
Recruiting
Allogeneic CD19-targeted CAR-ฮณฮดT Cell Infusion Therapy in Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
NCT06696833B-Cell Acute Lymphoblastic Leukemia, Adult
The First Affiliated Hospital of Soochow University
Phase EARLY_PHASE1
18
Suzhou
2024-12-01
Recruiting
SCS Therapy for Patients With Bladder and Bowel Dysfunction After SCI
NCT07511244Bladder and Bowel Dysfunction, SCI - Spinal Cord Injury
Beijing Tsinghua Chang Gung Hospital
Not applicable
10
Beijing
2024-12-01
Recruiting
Efficacy and Safety of Vorolanib Monotherapy As Third-line or Later Treatment for Advanced Non-small Cell Lung Cancer Patients: a Single-arm, Prospective, Open-label Phase II Clinical Study
NCT06728852Advanced Non-small Cell Lung Cancer (NSCLC), Recurrent or Metastatic Lung Cancer, Third-line and Beyond Therapy, Angiogenesis Inhibition in Oncology
Li-kun Chen
Phase 2
32
Guangzhou
2024-12-01
Recruiting
Effects of Cognitive Correction and Stimulus Control in Chronic Insomnia Patients
NCT06658158Chronic Insomnia
Xuanwu Hospital, Beijing
Not applicable
88
Beijing
2024-12-01
Rows per page Showing 10401–10500 of 19052
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=105

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.